Purinergic Receptors in Thrombosis and Inflammation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 11, 2015, Pages 2307-2315

  Hechler, Béatrice ^a,b,c   Gachet, Christian ^a,b,c  

^a INSERM   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

atherosclerosis; inflammation; nucleotides; platelets; sepsis; thrombosis

Indexed keywords

APOLIPOPROTEIN E; CD40 ANTIGEN; CD40 LIGAND; CLOPIDOGREL; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; NUCLEOTIDE; PADGEM PROTEIN; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFLAMMATORY AGENT; AUTACOID; FIBRINOLYTIC AGENT; P2XR RECEPTOR, HUMAN; PURINE DERIVATIVE; PURINERGIC P2 RECEPTOR; PURINERGIC P2 RECEPTOR AGONIST; PURINERGIC P2 RECEPTOR ANTAGONIST;

ALLERGIC ASTHMA; ARTERY THROMBOSIS; ASTHMA; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CRYSTAL STRUCTURE; ENDOTOXEMIA; HEMOSTASIS; HUMAN; NEOINTIMA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESTENOSIS; REVIEW; THROMBOCYTE AGGREGATION; THROMBOSIS; UPREGULATION; VASCULITIS; ANIMAL; BLOOD; BLOOD CLOTTING; DRUG EFFECTS; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD COAGULATION; FIBRINOLYTIC AGENTS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; PURINERGIC P2 RECEPTOR AGONISTS; PURINERGIC P2 RECEPTOR ANTAGONISTS; PURINES; RECEPTORS, PURINERGIC P2; RECEPTORS, PURINERGIC P2X7; RECEPTORS, PURINERGIC P2Y2; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 84945459239     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.303395     Document Type: Review

References (80)

1. Burnstock G, Ralevic V, Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 2014 66 102 192. doi: 10.1124/pr.113.008029
2. Junger WG, Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol 2011 11 201 212. doi: 10.1038/nri2938
3. Yegutkin GG, Nucleotide-and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008 1783 673 694. doi: 10.1016/j.bbamcr.2008.01.024
4. Burnstock G, Purine and pyrimidine receptors. Cell Mol Life Sci 2007 64 1471 1483. doi: 10.1007/s00018-007-6497-0
5. Gachet C, Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 2006 46 277 300. doi: 10.1146/annurev.pharmtox.46.120604.141207
6. Gachet C, P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells. Purinergic Signal 2012 8 609 619. doi: 10.1007/s11302-012-9303-x
7. Gachet C, Léon C, Hechler B, The platelet P2 receptors in arterial thrombosis. Blood Cells Mol Dis 2006 36 223 227. doi: 10.1016/j.bcmd.2005.12.024
8. Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, Lachowicz JE, Zhang FL, Gustafson E, Monsma FJ Jr, Wiekowski MT, Abbondanzo SJ, Cook DN, Bayne ML, Lira SA, Chintala MS, Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001 107 1591 1598. doi: 10.1172/JCI12242
9. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB, Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001 409 202 207. doi: 10.1038/35051599
10. Harada K, Matsumoto Y, Umemura K, Adenosine diphosphate receptor P2Y12-mediated migration of host smooth muscle-like cells and leukocytes in the development of transplant arteriosclerosis. Transplantation 2011 92 148 154. doi: 10.1097/TP.0b013e318221d407
11. Wihlborg AK, Wang L, Braun OO, Eyjolfsson A, Gustafsson R, Gudbjartsson T, Erlinge D, ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 2004 24 1810 1815. doi: 10.1161/01.ATV.0000142376.30582.ed
12. Ben Addi A, Cammarata D, Conley PB, Boeynaems JM, Robaye B, Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. J Immunol 2010 185 5900 5906. doi: 10.4049/jimmunol.0901799
13. 12 receptor for adenosine diphosphate: congenital and drug-induced defects. Blood 2011 117 2102 2112. doi: 10.1182/blood-2010-08-263111
14. Depta JP, Bhatt DL, New approaches to inhibiting platelets and coagulation. Annu Rev Pharmacol Toxicol 2015 55 373 397. doi: 10.1146/annurev-pharmtox-010814-124438
15. Gachet C, Antiplatelet drugs: which targets for which treatments? J Thromb Haemost 2015 13 suppl 1 S313 S322. doi: 10.1111/jth.12947
16. Huber K, Bates ER, Valgimigli M, Wallentin L, Kristensen SD, Anderson JL, Lopez Sendon JL, Tubaro M, Granger CB, Bode C, Ohman EM, Steg PG, Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? Am Heart J 2014 168 611 621. doi: 10.1016/j.ahj.2014.06.014
17. Zhang K, Zhang J, Gao ZG, Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 2014 509 115 118. doi: 10.1038/nature13083
18. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH, Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999 5 1199 1202. doi: 10.1038/13522
19. Léon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C, Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 1999 104 1731 1737. doi: 10.1172/JCI8399
20. Léon C, Freund M, Ravanat C, Baurand A, Cazenave JP, Gachet C, Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation 2001 103 718 723
21. Hechler B, Gachet C, P2 receptors and platelet function. Purinergic Signal 2011 7 293 303. doi: 10.1007/s11302-011-9247-6
22. Hechler B, Nonne C, Roh EJ, Cattaneo M, Cazenave JP, Lanza F, Jacobson KA, Gachet C, MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′5′-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice. J Pharmacol Exp Ther 2006 316 556 563. doi: 10.1124/jpet.105.094037
23. Zhang D, Gao ZG, Zhang K, Two disparate ligand-binding sites in the human P2Y1 receptor. Nature 2015 520 317 321. doi: 10.1038/nature14287
24. Hechler B, Zhang Y, Eckly A, Cazenave JP, Gachet C, Ravid K, Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice. J Thromb Haemost 2003 1 155 163
25. Yang D, Chen H, Koupenova M, Carroll SH, Eliades A, Freedman JE, Toselli P, Ravid K, A new role for the A2b adenosine receptor in regulating platelet function. J Thromb Haemost 2010 8 817 827. doi: 10.1111/j.1538-7836.2010.03769.x
26. Mahaut-Smith MP, Jones S, Evans RJ, The P2X1 receptor and platelet function. Purinergic Signal 2011 7 341 356. doi: 10.1007/s11302-011-9224-0
27. Cattaneo M, Marchese P, Jacobson KA, Ruggeri Z, New insights into the role of P2X1 in platelet function. Haematologica 2002 87 13 14
28. Hechler B, Lenain N, Marchese P, Vial C, Heim V, Freund M, Cazenave JP, Cattaneo M, Ruggeri ZM, Evans R, Gachet C, A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med 2003 198 661 667. doi: 10.1084/jem.20030144
29. Oury C, Sticker E, Cornelissen H, De Vos R, Vermylen J, Hoylaerts MF, ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation. J Biol Chem 2004 279 26266 26273. doi: 10.1074/jbc.M402032200
30. Hechler B, Cattaneo M, Gachet C, The P2 receptors in platelet function. Semin Thromb Hemost 2005 31 150 161. doi: 10.1055/s-2005-869520
31. Dovlatova N, Wijeyeratne YD, Fox SC, Manolopoulos P, Johnson AJ, White AE, Latif ML, Ralevic V, Heptinstall S, Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor. Thromb Haemost 2008 100 261 270
32. Lazarowski ER, Harden TK, UDP-sugars as extracellular signaling molecules: cellular and physiologic consequences of P2Y14 receptor activation. Mol Pharmacol 2015 88 151 160. doi: 10.1124/mol.115.098756
33. Idzko M, Ferrari D, Eltzschig HK, Nucleotide signalling during inflammation. Nature 2014 509 310 317. doi: 10.1038/nature13085
34. Morrell CN, Aggrey AA, Chapman LM, Modjeski KL, Emerging roles for platelets as immune and inflammatory cells. Blood 2014 123 2759 2767. doi: 10.1182/blood-2013-11-462432
35. Cattaneo M, The platelet P2 receptors in inflammation. Hamostaseologie 2015 35 262 266. doi: 10.5482/HAMO-14-09-0044
36. Steinhubl SR, Badimon JJ, Bhatt DL, Herbert JM, Lüscher TF, Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med 2007 12 113 122
37. Rauch BH, Rosenkranz AC, Ermler S, Böhm A, Driessen J, Fischer JW, Sugidachi A, Jakubowski JA, Schrör K, Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions. Arterioscler Thromb Vasc Biol 2010 30 2434 2442. doi: 10.1161/ATVBAHA.110.213702
38. Evans DJ, Jackman LE, Chamberlain J, Crosdale DJ, Judge HM, Jetha K, Norman KE, Francis SE, Storey RF, Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis. Circulation 2009 119 116 122. doi: 10.1161/CIRCULATIONAHA.107.762690
39. Li D, Wang Y, Zhang L, Luo X, Li J, Chen X, Niu H, Wang K, Sun Y, Wang X, Yan Y, Chai W, Gartner TK, Liu J, Roles of purinergic receptor P2Y, G protein-coupled 12 in the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2012 32 e81 e89. doi: 10.1161/ATVBAHA.111.239095
40. West LE, Steiner T, Judge HM, Francis SE, Storey RF, Vessel wall, not platelet, P2Y12 potentiates early atherogenesis. Cardiovasc Res 2014 102 429 435. doi: 10.1093/cvr/cvu028
41. Abele S, Spriewald BM, Ramsperger-Gleixner M, Wollin M, Hiemann NE, Nieswandt B, Weyand M, Ensminger SM, Attenuation of transplant arteriosclerosis with clopidogrel is associated with a reduction of infiltrating dendritic cells and macrophages in murine aortic allografts. Transplantation 2009 87 207 216. doi: 10.1097/TP.0b013e3181938913
42. Gresele P, Todisco T, Merante F, Nenci GG, Platelet activation and allergic asthma. N Engl J Med 1982 306 549. doi: 10.1056/NEJM198203043060920
43. Paruchuri S, Tashimo H, Feng C, Maekawa A, Xing W, Jiang Y, Kanaoka Y, Conley P, Boyce JA, Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med 2009 206 2543 2555. doi: 10.1084/jem.20091240
44. 1 receptor controls leukocyte recruitment in allergic mice. J Allergy Clin Immunol 2015 135 528 538. doi: 10.1016/j.jaci.2014.09.032
45. Asaduzzaman M, Lavasani S, Rahman M, Zhang S, Braun OO, Jeppsson B, Thorlacius H, Platelets support pulmonary recruitment of neutrophils in abdominal sepsis. Crit Care Med 2009 37 1389 1396. doi: 10.1097/CCM.0b013e31819ceb71
46. de Stoppelaar SF, Van't Veer C, Roelofs JJ, Claushuis TA, de Boer OJ, Tanck MW, Hoogendijk AJ, van der Poll T, Platelet and endothelial cell P-selectin are required for host defense against Klebsiella pneumoniae-induced pneumosepsis. J Thromb Haemost 2015 13 1128 1138. doi: 10.1111/jth.12893
47. Rahman M, Gustafsson D, Wang Y, Thorlacius H, Braun OÖ Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis. Platelets 2014 25 257 263. doi: 10.3109/09537104.2013.809520
48. Hagiwara S, Iwasaka H, Hasegawa A, Oyama M, Imatomi R, Uchida T, Noguchi T, Adenosine diphosphate receptor antagonist clopidogrel sulfate attenuates LPS-induced systemic inflammation in a rat model. Shock 2011 35 289 292. doi: 10.1097/SHK.0b013e3181f48987
49. Garcia AE, Mada SR, Rico MC, Dela Cadena RA, Kunapuli SP, Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis. PLoS One 2011 6 e26035. doi: 10.1371/journal.pone.0026035
50. Leon C, Ravanat C, Freund M, Cazenave JP, Gachet C, Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity. Arterioscler Thromb Vasc Biol 2003 23 1941 1947. doi: 10.1161/01.ATV.0000092127.16125.E6
51. Hechler B, Freund M, Ravanat C, Magnenat S, Cazenave JP, Gachet C, Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Circulation 2008 118 754 763. doi: 10.1161/CIRCULATIONAHA.108.788927
52. 1receptor in purinergic regulation of TNFα-induced vascular inflammation. Circulation 2011 123 2404 2413. doi: 10.1161/CIRCULATIONAHA.110.002139
53. Dinarvand P, Hassanian SM, Qureshi SH, Manithody C, Eissenberg JC, Yang L, Rezaie AR, Polyphosphate amplifies proinflammatory responses of nuclear proteins through interaction with receptor for advanced glycation end products and P2Y1 purinergic receptor. Blood 2014 123 935 945. doi: 10.1182/blood-2013-09-529602
54. Liu R, Ma S, Lu Z, Shen H, Sun L, Wei M, The ADP antagonist MRS2179 regulates the phenotype of smooth muscle cells to limit intimal hyperplasia. Cardiovasc Drugs Ther 2015 29 23 29. doi: 10.1007/s10557-014-6561-6
55. Marques-da-Silva C, Burnstock G, Ojcius DM, Coutinho-Silva R, Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Immunobiology 2011 216 1 11
56. Lecut C, Frederix K, Johnson DM, Deroanne C, Thiry M, Faccinetto C, Marée R, Evans RJ, Volders PG, Bours V, Oury C, P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation. J Immunol 2009 183 2801 2809. doi: 10.4049/jimmunol.0804007
57. Maître B, Magnenat S, Heim V, Ravanat C, Evans RJ, de la Salle H, Gachet C, Hechler B, The P2X1 receptor is required for neutrophil extravasation during lipopolysaccharide-induced lethal endotoxemia in mice. J Immunol 2015 194 739 749. doi: 10.4049/jimmunol.1401786
58. Darbousset R, Delierneux C, Mezouar S, Hego A, Lecut C, Guillaumat I, Riederer MA, Evans RJ, Dignat-George F, Panicot-Dubois L, Oury C, Dubois C, P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice. Blood 2014 124 2575 2585. doi: 10.1182/blood-2014-04-571679
59. Di Virgilio F, Vuerich M, Purinergic signaling in the immune system. Auton Neurosci 2015 191 117 123. doi: 10.1016/j.autneu.2015.04.011
60. Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S, Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell 2013 24 130 137. doi: 10.1016/j.ccr.2013.05.008
61. Seye C, Weisman G, Gerasimovskaya E, Kaczmarek E, The P2Y2 nucleotide receptor in vascular inflammation and angiogenesis. Extracellular ATP and Adenosine as Regulators of Endothelial Cell Function: Implications for Health and Disease 2010 Heidelberg, Germany: Springer Science & Business Media 57 72. In
62. Stachon P, Peikert A, Michel A, Wolf D, Hoppe N, Dufner B, Bode C, Idzko M, Zirlik A, Extracellular ATP induces atherosclerosis and vascular inflammation via purinergic receptor 2 (P2Y2) in mice. Cardiovasc Res 2014 103 S97. doi: 10.1093/cvr/cvu093.1
63. Stokes L, Surprenant A, Purinergic P2Y2 receptors induce increased MCP-1/CCL2 synthesis and release from rat alveolar and peritoneal macrophages. J Immunol 2007 179 6016 6023
64. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS, Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009 461 282 286. doi: 10.1038/nature08296
65. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P, Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010 330 362 366. doi: 10.1126/science.1195491
66. Inoue Y, Chen Y, Hirsh MI, Yip L, Junger WG, A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis. Shock 2008 30 173 177. doi: 10.1097/shk.0b013e318160dad4
67. Riegel AK, Faigle M, Zug S, Rosenberger P, Robaye B, Boeynaems JM, Idzko M, Eltzschig HK, Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood 2011 117 2548 2555. doi: 10.1182/blood-2010-10-313957
68. Garcia RA, Yan M, Search D, P2Y6 receptor potentiates pro-inflammatory responses in macrophages and exhibits differential roles in atherosclerotic lesion development. PLoS One 2014 9 e111385. doi: 10.1371/journal.pone.0111385
69. Zhang Z, Wang Z, Ren H, Yue M, Huang K, Gu H, Liu M, Du B, Qian M, P2Y(6) agonist uridine 5′-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocytes/macrophages recruitment. J Immunol 2011 186 5376 5387. doi: 10.4049/jimmunol.1002946
70. Stachon P, Peikert A, Michel NA, P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2014 34 2237 2245. doi: 10.1161/ATVBAHA.114.303585
71. Müller T, Robaye B, Vieira RP, Ferrari D, Grimm M, Jakob T, Martin SF, Di Virgilio F, Boeynaems JM, Virchow JC, Idzko M, The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy 2010 65 1545 1553. doi: 10.1111/j.1398-9995.2010.02426.x
72. Vieira RP, Müller T, Grimm M, Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammation. Am J Respir Crit Care Med 2011 184 215 223. doi: 10.1164/rccm.201011-1762OC
73. Müller T, Vieira RP, Grimm M, Dürk T, Cicko S, Zeiser R, Jakob T, Martin SF, Blumenthal B, Sorichter S, Ferrari D, Di Virgillio F, Idzko M, A potential role for P2X7R in allergic airway inflammation in mice and humans. Am J Respir Cell Mol Biol 2011 44 456 464. doi: 10.1165/rcmb.2010-0129OC
74. Bartlett R, Stokes L, Sluyter R, The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev 2014 66 638 675. doi: 10.1124/pr.113.008003
75. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F, The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006 176 3877 3883
76. Manthei DM, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Gern JE, Lemanske RF Jr, Denlinger LC, Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function. J Allergy Clin Immunol 2012 130 496 502. doi: 10.1016/j.jaci.2012.05.040
77. Bhattacharya A, Neff RA, Wickenden AD, The physiology, pharmacology and future of P2X7 as an analgesic drug target: hype or promise? Curr Pharm Biotechnol 2011 12 1698 1706
78. Furlan-Freguia C, Marchese P, Gruber A, Ruggeri ZM, Ruf W, P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest 2011 121 2932 2944. doi: 10.1172/JCI46129
79. Rothmeier AS, Marchese P, Petrich BG, Furlan-Freguia C, Ginsberg MH, Ruggeri ZM, Ruf W, Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles. J Clin Invest 2015 125 1471 1484. doi: 10.1172/JCI79329
80. Sesma JI, Kreda SM, Steinckwich-Besancon N, Dang H, García-Mata R, Harden TK, Lazarowski ER, The UDP-sugar-sensing P2Y(14) receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils. Am J Physiol Cell Physiol 2012 303 C490 C498. doi: 10.1152/ajpcell.00138.2012